RU2415673C2 - Композиция с фиксированной дозой фитата и цинка - Google Patents

Композиция с фиксированной дозой фитата и цинка Download PDF

Info

Publication number
RU2415673C2
RU2415673C2 RU2008138358/15A RU2008138358A RU2415673C2 RU 2415673 C2 RU2415673 C2 RU 2415673C2 RU 2008138358/15 A RU2008138358/15 A RU 2008138358/15A RU 2008138358 A RU2008138358 A RU 2008138358A RU 2415673 C2 RU2415673 C2 RU 2415673C2
Authority
RU
Russia
Prior art keywords
phytate
hydroxyapatite
composition
calcification
zinc
Prior art date
Application number
RU2008138358/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008138358A (ru
Inventor
ФРЕЙКСЕДАС Феликс ГРАСЕС (ES)
ФРЕЙКСЕДАС Феликс ГРАСЕС
БЕСТАРД Хоан ПЕРЕЛЛО (ES)
БЕСТАРД Хоан ПЕРЕЛЛО
АМЕНГУАЛ Бернат ИСЕРН (ES)
АМЕНГУАЛ Бернат ИСЕРН
КОРТЕС Пилар САНЧИС (ES)
КОРТЕС Пилар САНЧИС
АЛЬМИРАЛЛЬ Рафаэль М. ПРЬЕТО (ES)
АЛЬМИРАЛЛЬ Рафаэль М. ПРЬЕТО
БАУСА Антония КОСТА (ES)
БАУСА Антония КОСТА
Original Assignee
Университат Де Ле Илле Балеарс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Университат Де Ле Илле Балеарс filed Critical Университат Де Ле Илле Балеарс
Publication of RU2008138358A publication Critical patent/RU2008138358A/ru
Application granted granted Critical
Publication of RU2415673C2 publication Critical patent/RU2415673C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Catalysts (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Dental Preparations (AREA)
RU2008138358/15A 2006-02-17 2007-02-14 Композиция с фиксированной дозой фитата и цинка RU2415673C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP-200600377 2006-02-17
ES200600377A ES2280136B1 (es) 2006-02-17 2006-02-17 Asociacion a dosis fija de fitato y zinc.

Publications (2)

Publication Number Publication Date
RU2008138358A RU2008138358A (ru) 2010-03-27
RU2415673C2 true RU2415673C2 (ru) 2011-04-10

Family

ID=38007006

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008138358/15A RU2415673C2 (ru) 2006-02-17 2007-02-14 Композиция с фиксированной дозой фитата и цинка

Country Status (18)

Country Link
US (2) US8377908B2 (enExample)
EP (1) EP1984001B1 (enExample)
JP (2) JP5554499B2 (enExample)
CN (1) CN101384266B (enExample)
AT (1) ATE516035T1 (enExample)
AU (1) AU2007216453B2 (enExample)
BR (1) BRPI0707008A2 (enExample)
CA (1) CA2641216C (enExample)
CY (1) CY1111913T1 (enExample)
DK (1) DK1984001T3 (enExample)
ES (1) ES2280136B1 (enExample)
MX (1) MX2008010502A (enExample)
NO (1) NO341286B1 (enExample)
PL (1) PL1984001T3 (enExample)
PT (1) PT1984001E (enExample)
RU (1) RU2415673C2 (enExample)
SI (1) SI1984001T1 (enExample)
WO (1) WO2007093611A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2578967C2 (ru) * 2011-07-12 2016-03-27 Дзе Проктер Энд Гэмбл Компани Композиции для ухода за полостью рта, содержащие фитиновую кислоту

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
BR112017012809B1 (pt) 2014-12-26 2020-09-24 Colgate-Palmolive Company Composição para higiene bucal e uso de um complexo de polifosfato de zinco solúvel na preparação da mesma
DE102016013737A1 (de) 2016-11-17 2018-05-17 WindplusSonne GmbH Hexahydroxycyclohexanhexaphosphorsäureestersalze zur Behandlung von Kalzinose sowie diätische Lebensmittel mit Hexahydroxycyclohexanhexaphosphorsäureestersalzen als Zusatzstoffe
CN108444985B (zh) * 2018-04-25 2021-02-02 山西省食品药品检验所(山西省药品包装材料监测中心) 一种肾精子icp-ms鉴别方法及应用
US20210347793A1 (en) * 2018-09-18 2021-11-11 Inositec Ag Calcium oxalate crystallization inhibitors for renal disorders
US11633416B1 (en) 2020-03-06 2023-04-25 Arcus Biosciences, Inc. Oral formulations of CD73 compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300289A (en) * 1991-12-10 1994-04-05 The Dow Chemical Company Phytate antimicrobial compositions in oral care products
CN1593376A (zh) * 2004-06-24 2005-03-16 江西航天日用化工发展有限责任公司 可去除烟黄斑牙垢的复方牙膏及其制备方法
WO2005044278A1 (en) * 2003-11-07 2005-05-19 Laboratorios Sanifit, S.L. Myo-inositol hexaphosphate for topical use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934001A (en) * 1965-12-07 1976-01-20 Lever Brothers Company Oral compositions containing germicidally active plastic powders
NL149701C (nl) 1965-12-08 1981-05-15 Procter & Gamble Werkwijze voor het bereiden van een tegen tandsteen werkzaam tandverzorgingsmiddel, dat als werkzaam bestanddeel een fosfonzuurderivaat bevat, alsmede gevormd tandverzorgingsmiddel.
US3934002A (en) 1972-06-30 1976-01-20 The Procter & Gamble Company Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies
US4215105A (en) 1978-10-27 1980-07-29 Colgate-Palmolive Company Anticalculus oral composition
JPS5846483B2 (ja) * 1979-09-20 1983-10-17 ライオン株式会社 口腔用組成物
JPS5835965B2 (ja) 1979-07-31 1983-08-05 ライオン株式会社 口腔用組成物
JPS6043322B2 (ja) * 1979-09-05 1985-09-27 ライオン株式会社 口腔用組成物
US4515772A (en) * 1982-06-22 1985-05-07 The Procter & Gamble Company Oral compositions
US4808409A (en) 1984-08-16 1989-02-28 Board Of Trustees, University Of Illinois Low cariogenic sweetening agents
JPS6229526A (ja) * 1985-08-01 1987-02-07 Wakamoto Pharmaceut Co Ltd 高カルシウム尿症の治療及び予防剤
US4808401A (en) * 1985-09-13 1989-02-28 Colgate-Palmolive Company Anticalculus oral composition
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
JPH0729909B2 (ja) * 1986-11-28 1995-04-05 ライオン株式会社 口腔用組成物
JPH01305033A (ja) * 1988-06-01 1989-12-08 Sanwa Kagaku Kenkyusho Co Ltd 循環改善剤及び循環改善機能性食品並びにし好品
ES2007238A6 (es) * 1988-06-17 1989-06-01 Univ Illes Balears Procedimiento para la preparacion de fitato-zn (ii)>
US5286479A (en) * 1991-12-10 1994-02-15 The Dow Chemical Company Oral compositions for suppressing mouth odors
CN1102978A (zh) * 1993-11-23 1995-05-31 姚焕新 多功能牙膏
JPH08104635A (ja) * 1994-10-06 1996-04-23 Ichimaru Pharcos Co Ltd フィチン酸亜鉛を有効成分とする外用製剤
JPH10182383A (ja) * 1996-12-24 1998-07-07 Lion Corp 口腔用組成物
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
JP2004065249A (ja) * 2002-06-13 2004-03-04 Fumio Hara フィチン酸、イノシトールおよびナイアシンの富化方法、食品の製造方法、並びに食品
BRPI0619389A2 (pt) * 2005-11-29 2011-10-04 Procter & Gamble composição dentifrìcia compreendendo um sistema aglutinante que compreende material de argila hidrofìlica
CA2634758A1 (en) * 2005-12-20 2007-07-05 The Procter & Gamble Company Oral care compositions comprising zinc and phytate
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300289A (en) * 1991-12-10 1994-04-05 The Dow Chemical Company Phytate antimicrobial compositions in oral care products
WO2005044278A1 (en) * 2003-11-07 2005-05-19 Laboratorios Sanifit, S.L. Myo-inositol hexaphosphate for topical use
CN1593376A (zh) * 2004-06-24 2005-03-16 江西航天日用化工发展有限责任公司 可去除烟黄斑牙垢的复方牙膏及其制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Grases F et al. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci. 2006 Jan 1; 11:136-42 (реферат PMID: 16146720) [он-лайн] [найдено 2010-03-31]. Найдено из базы данных PubMed Grases F et al. Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis. Br J Dermatol. 2005 May; 152(5): 1022-5 (реферат PMID: 15888163) [он-лайн] [найдено 2010-03-31]. Найдено из базы данных PubMed Grases F et al. Effects of phytic acid on renal stone formation in rats. Scand J Urol Nephrol. 1998 Jul; 32(4):261-5; реферат PMID: 9764452 [он-лайн] [найдено 2010-03-31]. Найдено из базы данных PubMed. *
ГЛИНКА Н.Л. Общая химия. - М.-Л.: ГОСУДАРСТВЕННОЕ НАУЧНО-ТЕХНИЧЕСКОЕ ИЗД-ВО ХИМИЧЕСКОЙ ЛИТЕРАТУРЫ, 1954, с.270-271. *
Реферат [он-лайн] [найдено 2009-12-22]. Найдено из базы данных esp@cenet. ШАНИН В.Ю. Клиническая патофизиология. - СПб.: Специальная литература, 1998, с.489. ЗАЙЧИК А.Ш. и др. Основы патохимии. - ЭЛБИ-СПб, 2000, с.640. ПАЛЬЦЕВ М.А. и др. Патологическая анатомия. - М.: Медицина, 2001, т.2, ч.1, с.30, ч.2, с.84, с.344. *
статья Myo-inositol [N:63903-51-5] (реферат) [он-лайн] [найдено 2010-03-31]. Найдено из базы данных ChemIDplus Advanced. статья Calcium phosphate, tribasic [RN: 12167-74-7] (реферат) [он-лайн] [найдено 2010-04-01]. Найдено из базы данных ChemIDplus. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2578967C2 (ru) * 2011-07-12 2016-03-27 Дзе Проктер Энд Гэмбл Компани Композиции для ухода за полостью рта, содержащие фитиновую кислоту

Also Published As

Publication number Publication date
JP2014139182A (ja) 2014-07-31
PL1984001T3 (pl) 2012-02-29
US9144578B2 (en) 2015-09-29
SI1984001T1 (sl) 2011-12-30
EP1984001B1 (en) 2011-07-13
PT1984001E (pt) 2011-10-18
MX2008010502A (es) 2008-10-23
ATE516035T1 (de) 2011-07-15
ES2280136B1 (es) 2008-08-16
US20090035232A1 (en) 2009-02-05
US20140056994A1 (en) 2014-02-27
AU2007216453B2 (en) 2012-09-27
RU2008138358A (ru) 2010-03-27
JP5554499B2 (ja) 2014-07-23
JP2009526818A (ja) 2009-07-23
CA2641216A1 (en) 2007-08-23
ES2280136A1 (es) 2007-09-01
JP5908933B2 (ja) 2016-04-26
DK1984001T3 (da) 2011-11-07
CN101384266B (zh) 2013-03-20
CA2641216C (en) 2014-04-15
CN101384266A (zh) 2009-03-11
BRPI0707008A2 (pt) 2011-04-12
EP1984001A1 (en) 2008-10-29
US8377908B2 (en) 2013-02-19
WO2007093611A1 (en) 2007-08-23
NO341286B1 (no) 2017-10-02
AU2007216453A1 (en) 2007-08-23
NO20083901L (no) 2008-09-11
CY1111913T1 (el) 2015-11-04

Similar Documents

Publication Publication Date Title
RU2415673C2 (ru) Композиция с фиксированной дозой фитата и цинка
US20100226866A1 (en) Solid preparation for oral application
JP2006199702A (ja) 過飽和溶液中のカルシウムおよびリン酸イオンからなるうがい薬
ES2776402T3 (es) Composición que contiene ácido fítico, magnesio y polifenoles para el tratamiento o la prevención de la litiasis renal
GB2374008A (en) Compositions including copper and their uses
WO1995008332A1 (en) Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
FR2499408A1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
DE1813659C3 (de) Arzneimittel zur Verhinderung der anomalen Mobilisierung und Ablagerung von Calciumphosphat in menschlichen und tierischen Geweben
Rothwell et al. Does fish oil benefit stone formers?
WO1993023054A1 (en) Polyphosphorylated organic compounds: compositions useful in protecting biological tissues
AU651824B2 (en) Pharmaceutical composition
KR101088762B1 (ko) 에이코사펜타에노산을 포함하는 탈모 방지 및 발모 촉진용 나노하이브리드 복합체 및 발모 촉진용 조성물
Fleisch et al. Diphosphonates Mode of Action and Clinical Applications
CA2259997C (en) Remedies and preventives for stomatitis
JPS61233612A (ja) チユ−インガム
Bonjour Department of Pathophysiology, University of Berne, Berne, Switzerland
Abdulhadi et al. Hypocitraturia and its role in renal stone disease
Ingram et al. Calcium salt precipitation and mechanisms of inhibition under oral conditions
Berthon Metal-ligand Interactions in Biological fluids
Lander A Nutrient/Toxin Interaction Theory of the Etiology and Pathogenesis of Chronic Pain-Fatigue Syndromes: Part I
EA046793B1 (ru) Применение композиции (варианты) для профилактического или терапевтического лечения кальцификации сосудов
HK1101755A (en) Enhancement of magnesium uptake in mammals
JP2006193511A (ja) 糖尿病の治療のための医薬組成物

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20210215